Mirum Pharmaceuticals, Inc. (MIRM): Submission of Matters to a Vote of Security Holders
Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001759425 0001759425 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15,
How this was made
The 30-second read
Why it matters
Confirms shareholder decisions on board composition, auditor ratification (Ernst & Young LLP), and advisory approval of executive compensation; no new financial or strategic disclosures are included.
Market read
Primarily governance/administrative information; unlikely to drive material repricing absent a contested outcome.
What to watch
Traders may still monitor whether any dissident actions or proxy contests are referenced elsewhere, but this specific 8-K only provides final vote counts.
Background
The SEC 8-K Item 5.07 reports matters submitted to a vote of security holders following Mirum’s 2026 annual meeting.
Ticker impact
Mirum Pharmaceuticals disclosed final voting results from its June 15, 2026 annual meeting, including director elections and say-on-pay approval.
Limited near-term impact; any reaction is likely small and short-lived unless investors were specifically contesting governance outcomes.
The filing reports election/ratification/advisory vote tallies without introducing new business developments, financial results, or regulatory/clinical catalysts.
Market effects
No direct read-across to the broader biotech/pharma sector from routine governance vote tallies.
None indicated; US-listed Nasdaq issuer filing.
None indicated.
Counterpoint
If there had been a close or failed say-on-pay or director election, it could signal governance risk; however, the disclosed results show approval/ratification outcomes without any stated controversy.
Key entities
- issuerMirum Pharmaceuticals, Inc.
Nasdaq-listed company filing the 8-K with final annual meeting voting results.
- auditorErnst & Young LLP
Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
